Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
R03AL01	ATROVENT COMP. HFA	B	Fenoterol Hydrobromide - 20mcg/actuation, Ipratropium bromide - 50mcg/actuation		Inhalation aerosol metered dose	544,256 L.L
R03BB01	ATROVENT N	B	Ipratropium bromide - 20mcg/actuation	20mcg/actuation	Inhalation aerosol metered dose	428,686 L.L
R03AL03	ANORO ELLIPTA	B	Vilanterol - 25mcg, Umeclidinium bromide - 62.5mcg		Inhalation powder	5,367,774 L.L
R03AC02	ASTHALIN	G	Salbutamol (sulfate) - 2.5mg/2.5ml	2.5mg/2.5ml	Inhalation solution	325,210 L.L
R03BB01	ATROVENT	B	Ipratropium bromide - 250mcg/2ml	250mcg/2ml	Inhaltion solution with nebuliser	544,256 L.L
R03BB01	ATROVENT	B	Ipratropium bromide - 500mcg/2ml	500mcg/2ml	Inhaltion solution with nebuliser	713,580 L.L
A16AB05	ALDURAZYME	B	Laronidase - 100U/ml	100U/ml	Injectable concentrate for solution	57,138,680 L.L
B05XA31	ADDAVEN	G	Chromic chloride 6H2O - 53mcg/10ml, Copper chloride dihydrate - 1.02mg/10ml, Ferric Chloride hexahydrate - 5.40mg/10ml, Manganese chloride 4H2O - 198mcg/10ml, Potassium iodide - 166mcg/10ml, Sodium fluoride - 2.10mg/10ml		Injectable concentrate for solution	4,065,124 L.L
L01BA04	ALIMTA	B	Pemetrexed (disodium) - 500mg	500mg	Injectable concentrated powder for solution	78,813,513 L.L
L01BA04	ALIMTA	B	Pemetrexed (disodium) - 100mg	100mg	Injectable concentrated powder for solution	16,854,009 L.L
L04AC07	ACTEMRA	BioTech	Tocilizumab - 80mg/4ml	80mg/4ml	Injectable concentrated solution	11,127,864 L.L
L01FG01	AVASTIN	BioTech	Bevacizumab - 400mg/16ml	400mg/16ml	Injectable concentrated solution	75,875,312 L.L
L04AC07	ACTEMRA	BioTech	Tocilizumab - 200mg/10ml	200mg/10ml	Injectable concentrated solution	25,485,937 L.L
L01FG01	AVASTIN	BioTech	Bevacizumab - 400mg	400mg	Injectable concentrated solution	75,875,312 L.L
L04AC07	ACTEMRA	BioTech	Tocilizumab - 400mg/20ml	400mg/20ml	Injectable concentrated solution	47,925,322 L.L
L01FG01	AVASTIN	BioTech	Bevacizumab - 100mg/4ml	100mg/4ml	Injectable concentrated solution	24,533,456 L.L
L01FG01	AVASTIN	BioTech	Bevacizumab - 100mg	100mg	Injectable concentrated solution	24,533,456 L.L
B01AC17	AGGRASTAT	B	Tirofiban hydrochloride monohydrate - 0.25mg/ml	0.25mg/ml	Injectable concentrated solution	18,280,324 L.L
B01AD02	ACTILYSE	BioTech	Alteplase - 50mg	50mg	Injectable dry powder for solution+diluent	100,976,426 L.L
L01BC07	AZACITIDINE NEAPOLIS	G	Azacitidine - 100mg	100mg	Injectable lyophilised powder	9,401,575 L.L
J05AB01	ASIMPLEX	G	Aciclovir - 250mg	250mg	Injectable lyophilised powder for solution	278,175 L.L
L01BC07	AZACITIDINE SHILPA	G	Azacitidine - 100mg	100mg	Injectable powder	7,350,062 L.L
L01BC07	AZACITIDINE SPC	G	Azacitidine - 100mg	100mg	Injectable powder	10,706,993 L.L
J07BX05	ABRYSVO	B	RSV subgroup A stabilized perfusion F antigen 60mcg - 60mcg, RSV subgroup B stabilized perfusion F antigen 60mcg - 60mcg, Glycoprotein F stabilized in the perfusion conformation -		Injectable powder + solvent	22,650,721 L.L
L01FX05	ADCETRIS	BioTech	Brentuximab Vedotin - 50mg	50mg	Injectable powder for concentrate for solution	L.L
L01FD01	ARYOTRUST	BioTech	Trastuzumab - 150mg	150mg	Injectable powder for concentrate for solution	21,176,745 L.L
L01FX05	ADCETRIS	BioTech	Brentuximab Vedotin - 50mg	50mg	Injectable powder for concentrate for solution	298,266,862 L.L
L01FD01	ARYOTRUST	BioTech	Trastuzumab - 440mg	440mg	Injectable powder for concentrate for solution + solvent	34,948,930 L.L
L01CD01	ABRAXANE	BioTech	Paclitaxel Albumin- bound - 5mg/ml	5mg/ml	Injectable powder for dispersion	17,850,751 L.L
J02AA01	AMBISOME	B	Liposomal Amphotericin B - 50mg	50mg	Injectable powder for liposomal dispersion	13,126,040 L.L

...